Vigil Neuroscience Stock Today
| VIGL Stock | USD 2.82 0.07 2.55% |
Performance0 of 100
| Odds Of DistressOver 58
|
Vigil Neuroscience is selling for 2.82 as of the 19th of April 2024. This is a 2.55 percent up since the beginning of the trading day. The stock's lowest day price was 2.58. Vigil Neuroscience has over 58 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Vigil Neuroscience are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 7th of January 2022 | Category Healthcare | Classification Health Care |
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Vigil Neuroscience, Inc. operates as a subsidiary of Amgen Inc. The company has 36.88 M outstanding shares of which 987.93 K shares are at this time shorted by private and institutional investors with about 8.68 trading days to cover. More on Vigil Neuroscience
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 8th of May 2024
Vigil Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vigil Neuroscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vigil Neuroscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Ivana JD | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Vigil Neuroscience report their recommendations after researching Vigil Neuroscience's financial statements, talking to executives and customers, or listening in on Vigil Neuroscience's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Vigil Neuroscience. The Vigil consensus assessment is calculated by taking the average forecast from all of the analysts covering Vigil Neuroscience. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Vigil Neuroscience's historical financial statements, Vigil Neuroscience is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Vigil Neuroscience is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Vigil Neuroscience's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Vigil Neuroscience's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Vigil Neuroscience's financial leverage. It provides some insight into what part of Vigil Neuroscience's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Vigil Neuroscience (VIGL) is traded on NASDAQ Exchange in USA. It is located in 100 Forge Road, Watertown, MA, United States, 02472 and employs 69 people. Vigil Neuroscience is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 101.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vigil Neuroscience's market, we take the total number of its shares issued and multiply it by Vigil Neuroscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vigil Neuroscience conducts business under Biotechnology sector and is part of Health Care industry. The entity has 36.88 M outstanding shares of which 987.93 K shares are at this time shorted by private and institutional investors with about 8.68 trading days to cover.
Vigil Neuroscience currently holds about 148.91 M in cash with (70.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Vigil Neuroscience Probability Of Bankruptcy
Ownership AllocationVigil Neuroscience shows a total of 36.88 Million outstanding shares. The majority of Vigil Neuroscience outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Vigil Neuroscience to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Vigil Neuroscience. Please pay attention to any change in the institutional holdings of Vigil Neuroscience as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Vigil Ownership Details
Vigil Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Vigil Neuroscience jumping above the current price in 90 days from now is about 90.88%. The Vigil Neuroscience probability density function shows the probability of Vigil Neuroscience stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.848. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Vigil Neuroscience will likely underperform. Additionally, vigil Neuroscience has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Vigil Neuroscience to move above the current price in 90 days from now is about 90.88 (This Vigil Neuroscience probability density function shows the probability of Vigil Stock to fall within a particular range of prices over 90 days) .
Vigil Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Vigil Neuroscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vigil Neuroscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vigil Neuroscience's value.| Instituion | Recorded On | Shares | |
| Orbimed Advisors, Llc | 2023-12-31 | 448.9 K | |
| Geode Capital Management, Llc | 2023-12-31 | 315.5 K | |
| Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2023-12-31 | 289.5 K | |
| State Street Corporation | 2023-12-31 | 283.3 K | |
| Ensign Peak Advisors Inc | 2023-12-31 | 228.7 K | |
| Anson Funds Management Lp | 2023-12-31 | 207 K | |
| Trustees Of Columbia University In The City Of New York | 2023-12-31 | 193 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 170.2 K | |
| Northern Trust Corp | 2023-12-31 | 141.4 K | |
| Northpond Ventures, Llc | 4.2 M | ||
| Citadel Advisors Llc | 2023-09-30 | 2.2 M |
Vigil Neuroscience Historical Income Statement
Vigil Neuroscience Income Statement is one of the three primary financial statements used for reporting Vigil's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Vigil Neuroscience revenue and expense. Vigil Neuroscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Vigil Neuroscience's Depreciation And Amortization is quite stable compared to the past year. Total Other Income Expense Net is expected to rise to about 6.5 M this year, although the value of Interest Expense will most likely fall to about 85.2 K. View More FundamentalsVigil Stock Against Markets
Picking the right benchmark for Vigil Neuroscience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vigil Neuroscience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vigil Neuroscience is critical whether you are bullish or bearish towards Vigil Neuroscience at a given time. Please also check how Vigil Neuroscience's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vigil Neuroscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Vigil Neuroscience Corporate Management
Elected by the shareholders, the Vigil Neuroscience's board of directors comprises two types of representatives: Vigil Neuroscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vigil. The board's role is to monitor Vigil Neuroscience's management team and ensure that shareholders' interests are well served. Vigil Neuroscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vigil Neuroscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA | Chief Officer | Profile | |
| Spyridon MD | Chief Officer | Profile | |
| Weeteck Yeo | Senior Operations | Profile | |
| Mr DABT | Senior Development | Profile | |
| Christopher JD | General Secretary | Profile | |
| Park CPA | Accounting Manager | Profile |
How to buy Vigil Stock?
Before investing in Vigil Neuroscience, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Vigil Neuroscience. To buy Vigil Neuroscience stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Vigil Neuroscience. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Vigil Neuroscience stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Vigil Neuroscience stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Vigil Neuroscience stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Vigil Neuroscience, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Vigil Stock please use our How to Invest in Vigil Neuroscience guide.
Already Invested in Vigil Neuroscience?
The danger of trading Vigil Neuroscience is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vigil Neuroscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vigil Neuroscience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vigil Neuroscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.Note that the Vigil Neuroscience information on this page should be used as a complementary analysis to other Vigil Neuroscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Vigil Stock analysis
When running Vigil Neuroscience's price analysis, check to measure Vigil Neuroscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vigil Neuroscience is operating at the current time. Most of Vigil Neuroscience's value examination focuses on studying past and present price action to predict the probability of Vigil Neuroscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vigil Neuroscience's price. Additionally, you may evaluate how the addition of Vigil Neuroscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Vigil Neuroscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.13) | Return On Assets (0.33) | Return On Equity (0.54) |
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.